Professor of Obstetrics and Gynecology, University VA School of Medicine
Obstetrics & Gynecology
Dr. Linda R. Duska, MD
|
|
Give Review
Linda Duska is an expert in the field of Obstetrics & Gynecology. She graduated from NYU School of Medicine. She over the years received 5 awards: "America's Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer", "Fellow (FACS)" and "Fellow (FACOG)". Linda R. Duska is also published. She has 79 publications published. The lastest publication: "Masculinizing sclerosing stromal cell tumor in pregnancy: report of a case and review of the literature.' Dr. Linda R. Duska is registered with Medicare.
Publications
- Risk factors for readmission in patients with ovarian, fallopian tube, and primary peritoneal carcinoma who are receiving front-line chemotherapy on a clinical trial (...
- Uterine carcinosarcoma: A review of the literature.
- Preoperative imaging of uterine malignancy: A low-value service.
- Severe Gastrointestinal Complications in the Era of Image-Guided High-Dose-Rate Intracavitary Brachytherapy for Cervical Cancer.
- Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a gynecologic oncology group study.
- A Phase II evaluation of ixabepilone (IND #59699, NSC #710428) in the treatment of recurrent or persistent leiomyosarcoma of the uterus: An NRG Oncology/Gynecologic On...
- Continuous epidural infusion anesthesia and analgesia in gynecologic oncology patients: Less pain, more gain?
- Improving quality of life in female cancer survivors: current status and future questions.
- Para-aortic Lymph Node Dissection for Women With Endometrial Adenocarcinoma and Intermediate- to High-Risk Tumors: Does It Improve Survival?
- Safety and success of the human papillomavirus vaccine: time for a robust vaccination program in the United States and worldwide.
- Randomized Multicenter Phase II Trial Comparing Two Schedules of Etirinotecan Pegol (NKTR-102) in Women With Recurrent Platinum-Resistant/Refractory Epithelial Ovarian...
- Imaging VCAM-1 as an Indicator of Treatment Efficacy in Metastatic Ovarian Cancer.
- Prevention of human papillomavirus-related malignancy: Access is the answer.
- The Patient Protection and Affordable Care Act: Impact on the care of gynecologic oncology patients in the absence of Medicaid expansion in Central Virginia.
- The Patient Protection and Affordable Care Act: What every provider of Gynecologic Oncology care should know.
- Melanotic xp11.2 neoplasm of the ovary: report of a unique case.
- Frailty: An outcome predictor for elderly gynecologic oncology patients.
- Does Significant Medical Comorbidity Negate the Benefit of Up-front Cytoreduction in Advanced Ovarian Cancer?
- Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.
- It's not just for laparoscopy anymore: Use of insufflation under ultrasound and fluoroscopic guidance by Interventional Radiologists for percutaneous placement of intr...
- Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and prim...
- The revolving door: Hospital readmissions of gynecologic oncology patients.
- SGO White Paper on ovarian cancer: etiology, screening and surveillance.
- When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial...
- Can we improve the detection of glandular cervical lesions: the role and limitations of the Pap smear diagnosis atypical glandular cells (AGC).
- Association of clear cell carcinoma of the endometrium with a high rate of venous thromboembolism.
- Abdominal radical trachelectomy: Success and pitfalls in a general gynecologic oncology practice.
- Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer.
- Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
- Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
- Negative laparoscopy is highly predictive of negative second-look laparotomy following chemotherapy for ovarian, tubal, and primary peritoneal carcinoma.
- Fertility-sparing surgery for ovarian low malignant potential tumors.
- Advances in the surgical management of ovarian cancer.
- Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
- A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "hig...
- Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro a...
- Surgical staging of ovarian low malignant potential tumors.
- Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer.
- Phase II trial of anastrozole in women with asymptomatic müllerian cancer.
- Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.
- Phase II study of liposomal doxorubicin and weekly paclitaxel for recurrent Müllerian tumors.
- Cervical adenocarcinoma survival among Hispanic and white women: a multicenter cohort study.
- Endocervical curettage at conization to predict residual cervical adenocarcinoma in situ.
- Paclitaxel and platinum chemotherapy for malignant mixed müllerian tumors of the ovary.
- Detection of female lower genital tract dysplasia using orally administered 5-aminolevulinic acid induced protoporphyrin IX: a preliminary study.
- Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
- Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.
- BAG-1 expression in normal and neoplastic endometrium.
- A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
- The role of cytoreductive surgery in the management of stage IV uterine papillary serous carcinoma.
- Endometrial cancer in women 40 years old or younger.
- Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia--a pilot study.
- Vulvar necrotizing soft tissue infection: A review of a multi-disciplinary surgical emergency and management in the modern era.
- Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease.
- Biodistribution of charged F(ab'')2 photoimmunoconjugates in a xenograft model of ovarian cancer.
- Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology.
- Fallopian tube carcinoma.
- Fertility options for patients with stages IA2 and IB cervical cancer: presentation of two cases and discussion of technical and ethical issues.
- Masculinizing sclerosing stromal cell tumor in pregnancy: report of a case and review of the literature.
- Predictors of recurrence in surgical stage II endometrial adenocarcinoma.
- Epithelial ovarian carcinoma in the reproductive age group.
- A Phase I study of continuous infusion doxorubicin and paclitaxel chemotherapy with granulocyte colony-stimulating factor for relapsed epithelial ovarian cancer.
- Clinically significant venous thromboembolism after gynecologic surgery.
- Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo.
- Efficacy and hematologic toxicity of salvage chemotherapy following stem cell-supported high-dose chemotherapy in women with recurrent ovarian cancer.
- Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis.
- A phase II trial of three sequential doublets for the treatment of advanced müllerian malignancies.
- Prolonged stabilization of platinum-resistant ovarian cancer in a single patient consuming a fermented soy therapy.
- Can the utility of secondary cytoreduction for ovarian cancer be reliably established?
- An approach to post-radical trachelectomy vaginal-isthmus cytology.
- Management of women with newly diagnosed ovarian cancer.
- Phase I/II dose finding study of combination cisplatin and gemcitabine in patients with recurrent cervix cancer.
- Psammoma bodies in cervicovaginal cytology specimens: a clinicopathological analysis of 31 cases.
- Comparison of the quality of life of early and advanced stage ovarian cancer survivors.
- Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
- Survivorship in Gynecologic Cancer: Enduring the Treatment toward a New Normal.
- Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel.
- Three sequential chemotherapy doublets for the treatment of newly diagnosed advanced müllerian malignancies: the modified triple doublet regimen.
Schools
New York University School Of Medicine
Johns Hopkins Hospital
John Hopkins Hospital
Ma Genl Hospital
Procedures Preformed
- Colpopexy
- Colporrhaphy
- Colposcopy
- Destruction or Excision of Vaginal Lesions
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Fellow (FACS)
- Fellow (FACOG)
Education
-
Massachusetts General Hospital -
Johns Hopkins University -
NYU School of Medicine
Hospital
-
University of Virginia Medical Center
Drug Facts
| NPI NUMBER | 1447241807 | |
| NPPES Provider LastName | DUSKA | |
| NPPES Provider FirstName | LINDA | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 247.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1447241807 |
| Last Name Of The Provider | DUSKA |
| First Name Of The Provider | LINDA |
| View All |
Similar Doctors
|
Dr. Willie A. Andersen, MD |
|
|
Dr. Siva Thiagarajah, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leigh A. Cantrell, MD |
|
Dr. Susan C. Modesitt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Peyton T. Taylor Jr., MD |
|
|
Dr. Michael L. Arnold, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly A. Owens, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amir A. Jazaeri, MD
This Doctor is OpenDoctor Recommended.
|